The U.S. National Institutes of Health (NIH) said on Wednesday that Jeanne Marrazzo had been selected to head its infectious diseases institute, months after its long-time director Anthony Fauci stepped down from the position.
Fauci is the top U.S. infectious disease official who became the face of America's response to the COVID-19 pandemic under Presidents Donald Trump and Joe Biden.
Hugh Auchincloss served as the acting head of the National Institute of Allergy and Infectious Diseases , after Fauci last year stepped down from the post he held since 1984. Marrazzo, currently the director of the division of infectious diseases at the University of Alabama at Birmingham, is expected to begin her role in the fall season, the NIH said in a statement.
The Biden administration had said in May that it intends to nominate cancer surgeon Dr. Monica Bertagnolli to lead the NIH, which is the largest biomedical research agency in the world.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Alabama doctor to replace Dr. Anthony Fauci at federal agencyFederal officials Wednesday named Dr. Jeanne Marrazzo from the University of Alabama at Birmingham as the new director of the National Institute of Allergy and Infectious Diseases (NIAID), the post previously held by Dr. Anthony Fauci.
Read more »
Virus remains Biden focus as NIH launches long COVID trialsThe National Institutes of Health on Monday said it’s launching trials to test drugs and other treatments for long COVID, a mysterious condition that affects millions of people after they catch the coronavirus.
Read more »
US NIH launches long-COVID trials of Pfizer's Paxlovid, other therapiesThe U.S. National Institutes of Health (NIH) said on Monday that it had launched mid-stage clinical trials to test at least four treatments, including Pfizer's Paxlovid, in patients with symptoms of long COVID.
Read more »
Biden administration opens new office to study long COVID response, NIH begins clinical trialsThe Department of Health and Human Services announced a new office will be studying long COVID as the National institutes of Health beings clinical trials for treatments.
Read more »
First long COVID treatment clinical trials from NIH getting underwayResearchers will test a range of potential treatments, from melatonin to Paxlovid, to see if they relieve symptoms of long COVID.
Read more »